查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927376

周邊血管減容器械市場依產品類型、臨床適應症、入路部位、最終用戶及通路分類－2026-2032年全球預測

Peripheral Vascular Debulking Device Market by Product Type, Clinical Indication, Access Site, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，周邊血管減容裝置市值將達到 117.2 億美元，到 2026 年將成長至 125.1 億美元，到 2032 年將達到 188.9 億美元，年複合成長率為 7.05%。

關鍵市場統計數據
基準年 2025 117.2億美元
預計年份：2026年 125.1億美元
預測年份 2032 188.9億美元
複合年成長率 (%) 7.05%

本文策略性地介紹了影響周邊血管減容裝置應用的臨床背景、技術發展歷程和採購考量。

周邊血管斑塊消融裝置在介入性心臟病學和血管外科的交叉領域佔據著至關重要的地位，它們能夠靶向斑塊修飾和病變準備，從而改善血管通暢性和手術效果。裝置動態、影像整合和導管設計的進步不斷拓展了這些系統的臨床效用，使臨床醫生能夠治療周邊和腎臟血管系統中更廣泛的複雜動脈粥狀硬化病變。臨床團隊在選擇動脈粥狀硬化斑塊切除術術時，通常會評估斑塊形態、鈣化負荷和病灶長度。同時，手術流程也越來越重視血管通路策略以及術前術後影像檢查，以最佳化治療效果並減少併發症。

深入剖析重塑醫療設備工程、臨床工作流程和價值論證的關鍵趨勢

隨著臨床需求、器材創新和醫療系統優先事項的整合，周邊血管減容器械領域正在迅速變化，產品價值提案也隨之重新定義。影像導引的手術規劃和術中指導正在重塑臨床醫生的選擇偏好，而高解析度血管內成像和融合技術則能夠更精確地評估病變並進行靶向減容。器械設計也在不斷演進，從單一用途的導管發展到可相容輔助性治療並提高多入路輸送能力的平台型設計。

對2025年關稅環境如何重塑設備相關人員的採購、定價策略與供應鏈韌性進行全面分析

2025年關稅政策的實施為周邊血管器械採購引入了新的變數，促使製造商和醫療系統重新評估籌資策略和成本結構。隨著零件和成品進口關稅的提高，製造商紛紛評估雙重採購安排和區域供應替代方案，以緩解利潤壓力。這種被動的資源重新配置往往導致短期營運調整，例如增加庫存緩衝、選擇性地本地化高價值零件以及重新談判供應商契約，以在保持品質標準的同時維持價格競爭力。

詳細的細分分析揭示了產品機制、臨床適應症、醫療環境、分銷模式和獲取策略如何共同決定了產品的採用趨勢。

對產品層面、終端用戶、臨床、分銷和手術途徑等細分領域的深入分析揭示了技術應用的實際機會和限制因素。按產品類型進行差異化仍然至關重要。定向動脈粥狀硬化斑塊切除術裝置，例如 SilverHawk 和 TurboHawk，專注於針對軟性纖維斑塊病變的靶向斑塊消融；而雷射系統，例如準分子雷射和 Nd:YAG 雷射，則提供適用於纖維化和血栓性閉塞的光消融機制。軌道式動脈粥狀硬化斑塊切除術有兩種類型——傳統軌道式和微振動式——由於其漸進式研磨作用，通常是重度鈣化病變的首選。旋轉式設備，例如 JetStream 和周邊旋轉消融器，可對局部鈣化狹窄進行高速旋轉消融。每種設備在機械性能、學習曲線、栓塞風險降低以及對輔助性治療選擇的影響方面都具有獨特的特點。

決定商業性和臨床成功的區域市場動態和戰略要務（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢對周邊血管技術的商業化策略、臨床應用和監管反應有顯著影響。在美洲，先進的臨床實踐模式、三級醫療中心的高手術量以及完善的報銷機制共同加速了新型減量手術方式的推廣應用。然而，由於公立和私立支付方的多樣性，強力的衛生經濟學證據和針對性的價值提案至關重要。歐洲、中東和非洲地區（EMEA）的管理體制和採購模式各不相同。市場准入需要協調一些國家集中式的監管體系與另一些國家分散式的醫院採購結構，而本地化的臨床數據和經銷夥伴對於技術的廣泛應用至關重要。

分析競爭格局，重點在於企業策略、證據產生、夥伴關係和服務模式。

該領域的競爭格局呈現出成熟平台供應商、專業化利基創新者和日益增多的新興企業之間的平衡，這些新創公司致力於推進新型消融機制和整合成像解決方案。現有企業通常利用其廣泛的服務網路、臨床培訓平台以及與醫院系統的長期合作關係來鞏固其首選供應商地位，而利基企業則透過設備特定的性能聲明、簡化的手術流程或針對特定適應症的臨床證據來脫穎而出。新興企業通常透過專注於迭代改進來建立臨床地位，例如降低栓塞風險、提高器械到達難入路部位的可行性以及最大限度地減少對操作者的依賴性。

為製造商和供應商提供可操作的策略性舉措，以加速產品應用、強化價值鏈並展現臨床和經濟價值。

產業領導者應優先採取一系列協調一致的策略行動，將產品開發、臨床證據和商業性執行有機結合，以最大限度地提高產品應用率和實現長期價值。首先，他們應投資於高品質的臨床證據，這些證據應能將器械選擇與手術成功率、肢體挽救率和降低再次干預率等重要終點直接聯繫起來，並優先開展能夠引起支付方和指南委員會共鳴的前瞻性註冊研究和比較研究。其次，他們應加強培訓和認證項目，以縮短學習曲線，並使介入性心臟病學和血管外科團隊的技術標準化，從而減少結果差異，增強臨床醫生的信心。

對用於得出基於證據的策略見解的多源研究框架、同行檢驗流程和分析保障措施進行透明描述

本分析的調查方法結合了多方面的證據收集、同行檢驗和迭代三角測量，從而得出可靠且可操作的結論。輔助研究活動包括對同行評審的臨床文獻進行系統性回顧、分析監管申報和醫療設備認證、評估臨床實踐指南以及評估手術編碼和報銷框架，以支持臨床和商業性背景。主要研究包括對介入性心臟病專家、血管外科醫生、採購負責人和分銷合作夥伴進行結構化訪談，以了解他們對醫療設備性能、培訓需求和採購因素的細緻看法。

一份權威的綜合分析報告，重點闡述了證據、營運韌性和跨職能策略在實現臨床和商業性成功方面發揮的關鍵作用。

一項綜合分析表明，周邊血管減容裝置正處於一個關鍵的轉折點，技術改進、循證醫學證據的累積以及與之匹配的商業模式將決定其未來的應用模式。裝置動態的進步以及與影像技術的整合拓展了其臨床應用範圍，但要在多種醫療環境中充分證明其安全性、有效性和成本效益，才是實現廣泛應用的關鍵。供應鏈的波動和政策的變化日益凸顯了營運韌性的重要性，迫使製造商和醫療系統重新評估其採購和合約策略。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊血管減容裝置市場（依產品類型分類）

  • 定向斑塊動脈粥狀硬化斑塊切除術
    • 銀鷹
    • 渦輪鷹
  • 雷射動脈動脈粥狀硬化斑塊切除術
    • 準分子雷射
    • Nd:YAG雷射
  • 軌道動脈粥狀動脈粥狀硬化斑塊切除術
    • 常規軌道
    • 微振動型
  • 旋切動脈粥狀硬化斑塊切除術
    • 急流
    • 末梢用旋轉器

9. 周邊血管減容器械市場（依臨床適應症分類）

  • 頸動脈狹窄
  • 嚴重肢體缺血
  • 周邊動脈疾病
  • 腎動脈狹窄

第10章 周邊血管減容器械市場（依入路部位分類）

  • 肱動脈路
  • 股動脈路徑
  • 徑向通道

第11章 周邊血管減容器械市場（按最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院
    • 循環系統
    • 血管外科

第12章 周邊血管減容器械市場（依通路分類）

  • 直銷
  • 批發的

13. 周邊血管減容器械市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 周邊血管減容器械市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國周邊血管減容器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國周邊血管減容器械市場

第17章 中國周邊血管減容器械市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Avinger, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cook Medical LLC
  • Koninklijke Philips NV
  • Medtronic plc
  • Straub Medical Group AG
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF384

The Peripheral Vascular Debulking Device Market was valued at USD 11.72 billion in 2025 and is projected to grow to USD 12.51 billion in 2026, with a CAGR of 7.05%, reaching USD 18.89 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.72 billion
Estimated Year [2026] USD 12.51 billion
Forecast Year [2032] USD 18.89 billion
CAGR (%) 7.05%

A strategic introduction outlining clinical context, technological evolution, and procurement imperatives shaping peripheral vascular debulking device adoption

Peripheral vascular debulking devices occupy a critical niche at the intersection of interventional cardiology and vascular surgery, providing targeted plaque modification and lesion preparation to improve vascular patency and procedural outcomes. Advances in device mechanics, imaging integration, and catheter design have progressively expanded the clinical utility of these systems, enabling clinicians to treat a broader spectrum of complex atherosclerotic lesions across peripheral and renal vasculature. Clinical teams now routinely evaluate plaque morphology, calcification burden, and lesion length when selecting an atherectomy modality, while procedural workflows increasingly prioritize vascular access strategy and peri-procedural imaging to optimize outcomes and reduce complications.

Against this clinical backdrop, stakeholders across industry, hospital procurement, and clinical practice face converging pressures to demonstrate value through procedural efficiency, consistent clinical outcomes, and alignment with evolving reimbursement and regulatory expectations. Technology roadmaps emphasize modular platforms, compatibility with adjunctive devices, and integrated data capture to support post-market evidence generation. Consequently, purchasers are weighing capital acquisition against service models and vendor-supported training. As new device generations emerge with refined mechanisms for calcified lesion modification and embolic protection integration, evaluating clinical differentiation, training burden, and supply chain resilience becomes essential for those seeking to adopt or expand the use of debulking technologies.

An incisive exploration of the major transformative trends reshaping device engineering, clinical workflows, and value demonstration across care settings

The landscape for peripheral vascular debulking devices is shifting rapidly as clinical expectations, device innovation, and health system priorities converge to redefine product value propositions. Imaging-driven procedural planning and intra-procedural guidance are reshaping operator preferences, with high-resolution intravascular imaging and fusion techniques enabling more precise lesion assessment and targeted debulking. Device designs continue to evolve from single-purpose catheters toward platform approaches that accommodate adjunctive therapies and provide improved deliverability across varied access sites.

Concurrently, care delivery models are moving procedures out of traditional inpatient settings into ambulatory surgery centers and hybrid suites, accelerating demand for devices that minimize procedural time and enable same-day discharge. This shift elevates the importance of robust training programs and simplified procedural workflows that reduce variability in operator performance. In parallel, emphasis on peri-procedural safety has intensified, leading to broader adoption of embolic protection strategies, adjunctive imaging, and post-procedural surveillance protocols. On the commercial front, manufacturers are responding with expanded service offerings, bundled contracting options, and digital tools that surface real-world performance metrics. Taken together, these transformative shifts are not only altering how devices are designed and used, but also how value is demonstrated to payers, providers, and patients.

A comprehensive analysis of how the 2025 tariff environment reshaped sourcing, pricing strategies, and supply chain resilience for device stakeholders

Tariff measures enacted in 2025 introduced a new variable into the procurement calculus for peripheral vascular devices, prompting manufacturers and health systems to reassess sourcing strategies and cost structures. Where component and finished-device imports were subject to increased duties, manufacturers expedited evaluation of dual-sourcing arrangements and regional supply alternatives to mitigate margin erosion. This reactive repositioning often translated into near-term operational adjustments such as increased inventory buffers, selective localization of high-value components, and renegotiation of supplier contracts to preserve price competitiveness while maintaining quality standards.

The cumulative effect extended to distribution channels and end users who experienced shifts in price transparency and procurement timelines. Hospitals and ambulatory centers faced intensified scrutiny over device selection, with purchasing committees requesting more comprehensive total-cost-of-ownership analyses and service-inclusive contracting to offset apparent unit cost increases. In response, some manufacturers accelerated investment in domestic assembly or contract manufacturing partnerships to reduce tariff exposure and demonstrate supply reliability. Regulatory and reimbursement dynamics also influenced behavior, as payers scrutinized any effective cost increases against clinical benefit. Overall, the tariff environment catalyzed a broader strategic realignment, encouraging supply chain diversification, tightened supplier relationships, and a renewed emphasis on operational resilience and commercial models that protect access while managing incremental cost pressure.

Detailed segmentation insights revealing how product mechanics, clinical indication, care setting, distribution model, and access strategy collectively determine adoption dynamics

Insight into product-level, end-user, clinical, distribution, and procedural access segmentation illuminates practical opportunities and constraints for technology diffusion. Product type differentiation remains foundational: directional atherectomy options such as platforms typified by SilverHawk and TurboHawk emphasize targeted plaque excision for soft and fibroatheromatous lesions, while laser-based systems, including Excimer Laser and Nd:YAG variants, offer photoablative mechanisms suited to fibrotic and thrombotic occlusions. Orbital atherectomy, available in conventional orbital and micro-oscillating designs, is often selected for its capacity to modify heavily calcified lesions with differential sanding action, whereas rotational modalities like Jetstream and Peripheral Rotablator deliver high-speed rotational ablation for focal calcified stenoses. Each modality carries distinct mechanical profiles, learning curves, and implications for embolic risk mitigation and adjunctive therapy selection.

End-user segmentation likewise influences adoption patterns: hospitals with dedicated cardiology and vascular surgery departments tend to be early adopters of advanced debulking technologies because of case complexity and procedural volume, whereas ambulatory surgery centers and clinics prioritize devices that support same-day throughput and streamlined logistics. Clinical indications drive device selection as well; carotid artery stenosis, critical limb ischemia, peripheral artery disease, and renal artery stenosis each present unique lesion morphologies and access considerations. Distribution channel dynamics-direct sales versus distributor networks-shape post-sale support, training, and bundled service offerings, while procedural access site choices such as brachial, femoral, and radial access impact device shaft design, catheter length, and sheath compatibility. Understanding how these segmentation layers interact provides actionable insight into where investment in evidence, training, and distribution will most effectively translate into adoption and clinical impact.

Regional market dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine commercial and clinical success

Regional dynamics exert a pronounced effect on commercialization strategies, clinical adoption, and regulatory navigation for peripheral vascular technologies. In the Americas, a combination of advanced clinical practice patterns, high procedure volumes in tertiary centers, and progressive reimbursement frameworks often accelerates uptake of novel debulking modalities, though private and public payer heterogeneity necessitates strong health economic evidence and targeted value propositions. Europe, the Middle East & Africa presents a mosaic of regulatory regimes and procurement models; market entry efforts must reconcile centralized regulation in some countries with decentralized hospital purchasing in others, making localized clinical data and distribution partnerships essential to scaling adoption.

In the Asia-Pacific region, rapid investment in interventional infrastructure and an expanding base of trained operators create significant runway for device penetration, but success requires attentiveness to manufacturing cost structures, regulatory timelines, and local clinical practice variations. Across all regions, translation of clinical innovation into sustainable adoption depends on aligning training, service support, and evidence generation with the unique procurement cadences and clinical priorities of each geography. Manufacturers that tailor commercial and clinical strategies to the regulatory contours and care-delivery models of each region stand a greater chance of achieving sustained engagement with healthcare providers and payers.

Competitive landscape analysis highlighting company strategies, evidence generation, partnerships, and service models that drive market differentiation

Competitive dynamics in this segment reflect a balance between established platform providers, specialized niche innovators, and an increasing number of agile startups advancing novel ablative mechanisms and integrated imaging solutions. Established firms typically leverage broad service networks, clinical training infrastructure, and long-term relationships with hospital systems to secure preferred-vendor status, while niche players differentiate through device-specific performance claims, simplified procedural workflows, or targeted clinical evidence in specialized indications. Emerging companies often focus on iterative improvements-reducing embolic risk, improving deliverability for challenging access sites, or minimizing operator-dependent variability-to carve clinical footholds.

Strategic imperatives for companies include expanding evidence portfolios through prospective registries and randomized comparisons, enhancing post-market surveillance capabilities, and developing service models that reduce the training burden for new operators. Partnerships with imaging vendors, consumable suppliers, and contract manufacturers are increasingly common as firms seek to offer integrated solutions and manage capital intensity. Mergers and acquisitions activity tends to center on acquiring complementary technology, consolidating distribution channels, or adding clinical capabilities that accelerate market penetration. For investors and corporate strategists, the most salient company-level indicators are the depth of clinical evidence, the robustness of post-sale service, and the flexibility of commercial models to meet diverse hospital and outpatient needs.

Actionable strategic initiatives for manufacturers and providers to accelerate adoption, strengthen supply chains, and demonstrate clinical and economic value

Industry leaders should prioritize a coordinated set of strategic actions that align product development, clinical evidence, and commercial execution to maximize uptake and long-term value capture. First, invest in high-quality clinical evidence that directly links device selection to meaningful endpoints such as procedural success, limb salvage, and reduced reintervention rates, and prioritize prospective registries and comparative studies that resonate with payers and guideline committees. Second, enhance training and credentialing programs that shorten learning curves and standardize techniques across interventional cardiology and vascular surgery teams, thereby reducing variability in outcomes and building clinician confidence.

Third, strengthen supply chain resilience through regional manufacturing partnerships, dual sourcing, and flexible inventory strategies to mitigate tariff exposure and logistical disruptions. Fourth, tailor commercial models by geography and care setting, offering bundled pricing, service-inclusive contracts, and data-driven support for hospital procurement teams to facilitate purchasing decisions. Fifth, emphasize integration with imaging and embolic protection solutions to address safety concerns and expand the range of treatable lesions. Finally, engage payers early with targeted health economic dossiers that articulate total-cost-of-care implications and support favorable reimbursement pathways. Implementing these complementary actions will help companies reduce adoption barriers, demonstrate sustainable clinical value, and secure advantageous position within evolving care pathways.

A transparent description of the multi-source research framework, expert validation processes, and analytic safeguards used to derive evidence-based strategic insights

The research methodology underpinning this analysis combined multi-source evidence collection, expert validation, and iterative triangulation to produce robust, actionable insights. Secondary research activities included systematic review of peer-reviewed clinical literature, analysis of regulatory filings and device approvals, assessment of clinical practice guidelines, and evaluation of procedural coding and reimbursement frameworks to ground clinical and commercial context. Primary research comprised structured interviews with interventional cardiologists, vascular surgeons, procurement professionals, and distribution partners to capture nuanced perspectives on device performance, training needs, and purchasing drivers.

Data synthesis employed triangulation across these sources to reconcile differences and identify consensus trends, while internal validity checks compared reported clinical outcomes with publicly available trial registries and post-market surveillance reports. Sensitivity analyses explored the operational impact of supply chain shocks and policy changes, and findings were peer-reviewed by external clinical advisors to ensure clinical plausibility and relevance. Recognized limitations include the evolving nature of clinical evidence and regional regulatory shifts that can change adoption dynamics; therefore, recommendations are presented with a focus on adaptability and monitoring protocols to update strategic assumptions as new data become available.

A conclusive synthesis highlighting the decisive role of evidence, operational resilience, and cross-functional strategy in realizing clinical and commercial success

The cumulative analysis underscores that peripheral vascular debulking devices are at an inflection point where technological refinement, evidence generation, and aligned commercial models will determine future adoption patterns. Advances in device mechanics and integration with imaging are enabling broader clinical applicability, yet adoption will hinge on convincing demonstrations of safety, efficacy, and cost-effectiveness across diverse care settings. Supply chain volatility and policy changes have raised the premium on operational resilience, prompting both manufacturers and health systems to reassess sourcing and contracting strategies.

Going forward, the organizations that succeed will be those that couple differentiated product performance with rigorous clinical evidence, scalable training programs, and flexible commercial arrangements that address the specific needs of hospitals, ambulatory centers, and clinics. Cross-functional collaboration-spanning R&D, clinical affairs, regulatory, and commercial teams-will be essential to translate innovation into repeatable clinical practice. By prioritizing these strategic levers, stakeholders can better navigate regulatory complexity, payer scrutiny, and procedural workflow constraints, ultimately improving patient outcomes while sustaining commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Debulking Device Market, by Product Type

  • 8.1. Directional Atherectomy
    • 8.1.1. SilverHawk
    • 8.1.2. TurboHawk
  • 8.2. Laser Atherectomy
    • 8.2.1. Excimer Laser
    • 8.2.2. NdYag Laser
  • 8.3. Orbital Atherectomy
    • 8.3.1. Conventional Orbital
    • 8.3.2. Micro-Oscillating
  • 8.4. Rotational Atherectomy
    • 8.4.1. Jetstream
    • 8.4.2. Peripheral Rotablator

9. Peripheral Vascular Debulking Device Market, by Clinical Indication

  • 9.1. Carotid Artery Stenosis
  • 9.2. Critical Limb Ischemia
  • 9.3. Peripheral Artery Disease
  • 9.4. Renal Artery Stenosis

10. Peripheral Vascular Debulking Device Market, by Access Site

  • 10.1. Brachial Access
  • 10.2. Femoral Access
  • 10.3. Radial Access

11. Peripheral Vascular Debulking Device Market, by End User

  • 11.1. Ambulatory Surgery Center
  • 11.2. Clinic
  • 11.3. Hospital
    • 11.3.1. Cardiology Department
    • 11.3.2. Vascular Surgery Department

12. Peripheral Vascular Debulking Device Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral Vascular Debulking Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral Vascular Debulking Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral Vascular Debulking Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral Vascular Debulking Device Market

17. China Peripheral Vascular Debulking Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Avinger, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardiovascular Systems, Inc.
  • 18.10. Cook Medical LLC
  • 18.11. Koninklijke Philips N.V.
  • 18.12. Medtronic plc
  • 18.13. Straub Medical Group AG
  • 18.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)